We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Waste Management (WM) Set to Acquire Avangard Innovative
Read MoreHide Full Article
Waste Management, Inc. (WM - Free Report) recently announced its plan to acquire Houston-based Avangard Innovative's U.S. business. This business will run as an independent company named Natura PCR under the primary ownership and control of WM.
Avangard and affiliated entities will have a collective minority equity position in Natura PCR. The deal is subject to customary closing conditions and is anticipated to be completed by the end of the year. The financial terms have been kept under wraps.
WM to Expand Foothold in PCR Market
Natura PCR plans to ramp up recycling capacities at Avangard's existing plant in Waller, TX, and build new plant capacity in the Midwest. In five years, it aims to produce 400 million pounds of post-consumer resin (PCR) per year through mechanical recycling of film and flexible plastics. This will help WM expand its foothold in the emerging PCR market.
“Today, there is so much untapped potential to reuse film – which impacts many of our commercial customers. We can help our customers close the loop and bring more recycled materials to the store shelf," said Jim Fish, president and CEO of WM.
Shares of WM have gained 11.2% over the past year against a 19.9% decline of the industry it belongs to.
Image: Bigstock
Waste Management (WM) Set to Acquire Avangard Innovative
Waste Management, Inc. (WM - Free Report) recently announced its plan to acquire Houston-based Avangard Innovative's U.S. business. This business will run as an independent company named Natura PCR under the primary ownership and control of WM.
Avangard and affiliated entities will have a collective minority equity position in Natura PCR. The deal is subject to customary closing conditions and is anticipated to be completed by the end of the year. The financial terms have been kept under wraps.
WM to Expand Foothold in PCR Market
Natura PCR plans to ramp up recycling capacities at Avangard's existing plant in Waller, TX, and build new plant capacity in the Midwest. In five years, it aims to produce 400 million pounds of post-consumer resin (PCR) per year through mechanical recycling of film and flexible plastics. This will help WM expand its foothold in the emerging PCR market.
“Today, there is so much untapped potential to reuse film – which impacts many of our commercial customers. We can help our customers close the loop and bring more recycled materials to the store shelf," said Jim Fish, president and CEO of WM.
Shares of WM have gained 11.2% over the past year against a 19.9% decline of the industry it belongs to.
Waste Management, Inc. Price
Waste Management, Inc. price | Waste Management, Inc. Quote
Zacks Rank and Stocks to Consider
Waste Management currently carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Services sector are Avis Budget Group, Inc. (CAR - Free Report) , Genpact Limited (G - Free Report) and CRA International, Inc. (CRAI - Free Report) .
Avis Budget sports a Zacks Rank #1 at present. CAR has an earnings growth rate of 108.4% for 2022.
Avis Budget delivered a trailing four-quarter earnings surprise of 69.5%, on average.
Genpact carries a Zacks Rank #2 (Buy) at present. G has a long-term earnings growth expectation of 12.3%.
Genpact delivered a trailing four-quarter earnings surprise of 10.1%, on average.
CRA International carries a Zacks Rank of 2, currently. CRAI has a long-term earnings growth expectation of 14.3%.
CRAI delivered a trailing four-quarter earnings surprise of 26%, on average.